Harnessing Breakthrough mRNA Liquid Biopsy to Transform Cancer Care and Accelerate Drug Development
ORDER A TESTCONTACT US
Wren Laboratories leverages the power of messenger RNA (mRNA) through advanced, minimally invasive liquid biopsy diagnostics.
Our breakthrough technology goes beyond traditional gene mutation detection by providing critical insights into mRNA activity—the dynamic that links genome abnormalities with disease behavior.
While next-generation sequencing (NGS) identifies gene alterations, not all mutations result in functional consequences. mRNA tells a deeper story: it carries the gene’s instructions—mutated or not—into biological action. These instructions lead to protein production, driving the cancer’s ability to grow and evade control.
Wren Laboratories’ proprietary RNA stabilization and testing platform enables a clearer, more functional view of tumor biology. RNA profiling detects aberrations in signaling pathways, the drivers of tumor behavior. These actionable insights empower drug development teams and cancer care providers to make more informed decisions, enabling improved therapeutic choices and more precisely targeted interventions.
Unlock the Power of Breakthrough mRNA Liquid Biopsy.
Products &
Services
Our multi-gene mRNA expression technology offers real-time, non-invasive cancer diagnostics for personalized treatment plans and patient monitoring.
Champion Personalized Cancer Care for Patients.
Patient Information
Essential information that patients and their oncologists need to know about our neuroendocrine and prostate cancer tests.
Accelerate Innovation in Precision Drug Discovery.
BioPharma & Research
Supporting drug development from discovery to companion diagnostic development. Our bioinformatics, quality system, and regulatory support ensures efficient and comprehensive solutions for biopharma partners.
Our Laboratory
Wren Laboratories, a Yale University spinoff, a CLIA, CAP, NYSDOH, and ISO15189-certified lab, is committed to advancing precision medicine through cutting-edge mRNA diagnostics, improving cancer care, and accelerating drug development.
Our Mission
Transform cancer diagnostics through innovative liquid biopsy mRNA technology.
Our Vision
Elevate cancer care and drive breakthroughs in drug development for better patient outcomes.
Our Key Innovations
Machine Learning
Diagnostics
Cutting-edge, multi-gene mRNA expression diagnostics for cancer detection, monitoring, and personalized management.
Clinical
Excellence
Over 115 patents, 60+ clinical studies, and 80+ peer-reviewed publications, collaborating with 45+ medical institutions in 15+ countries.
Why Choose Wren Laboratories?
-
Innovation: First-in-class mRNA diagnostics for better cancer outcomes.
-
Patient-centric: Diagnostics that prioritize accuracy, improve quality of life, and enhance treatment success.
-
Global Reach: Trusted by 45+ top medical institutions worldwide.
